Eli Lilly's acquisition spree shows no sign of stalling, although the Big Pharma is keeping the terms of its latest buy pretty vague. This time, Lilly has returned to antibody-drug conjugates (ADCs), ...
Hosted on MSN
Amy Goodman bio-doc resonates as press faces threats
Veteran U.S. independent journalist Amy Goodman is marking 30 years on the air for her news program with a documentary about her life and career. The premiere of "Steal This Story, Please!" is ...
HOUSTON--(BUSINESS WIRE)--CrossBridge Bio, Inc., a pre-clinical biotechnology company pioneering the development of next-generation dual-payload antibody-drug conjugates (ADCs) today announced a ...
Pharmaceutical giant Eli Lilly acquired Houston biotechnology startup CrossBridge Bio this week in a roughly $300 million deal. The startup, which is based out of the Texas Medical Center's innovation ...
Eli Lilly’s LLY-3.67%decrease; red down pointing triangle late-stage study of the efficacy and safety of a treatment for type 2 diabetes has produced positive results. Achieve-4, the longest phase 3 ...
Eli Lilly has handed AC Immune 10 million Swiss francs ($12.5 million) to expand their Alzheimer’s disease collaboration as a candidate moves closer to the clinic. The U.S. pharma first tapped up AC ...
Eli Lilly’s LLY2.55%increase; green up pointing triangle Foundayo weight-loss pill is now available in the U.S. following the Food and Drug Administration’s approval earlier this month, the company ...
Eli Lilly has chalked up another victory in the chronic lymphocytic leukemia (CLL) space, as its BTK inhibitor Jaypirca delivered its fourth positive phase 3 readout in the blood cancer. Monday, Lilly ...
The U.S. Food and Drug Administration has asked Eli Lilly for more data on liver injury linked to its newly approved obesity pill, according to a letter posted on the health regulator's website. The ...
Eli Lilly's newer weight-loss medicines will help cement its dominance in the market. The company could ride this tailwind through the medium term and deliver strong returns. Second, Eli Lilly's newer ...
Eli Lilly (LLY) reported Q4 revenue of $19.29B up 42.6% YoY, with Mounjaro generating $7.41B (up 110%) and Zepbound adding $4.26B (up 123%). Novo Nordisk (NVO) posted Q4 revenue down 7.6% YoY and cut ...
Al’Jaleel McGhee had been waiting for Levee Green. That’s the only explanation for this young actor’s truly astonishing performance as August Wilson’s impetuous young blues trumpeter, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results